These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9458489)

  • 1. A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two years.
    Pedersen EB; Bech JN; Nielsen CB; Kornerup HJ; Hansen HE; Spencer ES; Sølling J; Jensen KT
    Scand J Clin Lab Invest; 1997 Dec; 57(8):673-81. PubMed ID: 9458489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study.
    Herlitz H; Harris K; Risler T; Boner G; Bernheim J; Chanard J; Aurell M
    Nephrol Dial Transplant; 2001 Nov; 16(11):2158-65. PubMed ID: 11682661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
    Toto RD; Adams-Huet B; Fenves AZ; Mitchell HC; Mulcahy W; Smith RD
    Am J Kidney Dis; 1996 Dec; 28(6):832-40. PubMed ID: 8957034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
    Schnack C; Hoffmann W; Hopmeier P; Schernthaner G
    Diabetologia; 1996 Dec; 39(12):1611-6. PubMed ID: 8960851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P; Bilbous R; Mitchell T; O' Callaghan CJ; Viberti GC;
    Diabetes Care; 2000 Dec; 23(12):1823-9. PubMed ID: 11128360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition.
    Lytvyn Y; Kimura K; Peter N; Lai V; Tse J; Cham L; Perkins BA; Soleymanlou N; Cherney DZI
    Circulation; 2022 Aug; 146(6):450-462. PubMed ID: 35862082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of left ventricular hypertrophy by ACE-inhibitor, ramipril in comparison with calcium-channel antagonist, felodipine.
    Cacciapuoti F; Capasso A; Mirra G; De Nicola A; Minicucci F; Gentile S
    Int J Cardiol; 1998 Jan; 63(2):175-8. PubMed ID: 9510492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.
    Bainbridge AD; Macfadyen RJ; Stark S; Lees KR; Reid JL
    Br J Clin Pharmacol; 1993 Oct; 36(4):323-30. PubMed ID: 12959310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of felodipine on renal function and vasoactive hormones in infrarenal aortic surgery.
    de Lasson L; Hansen HE; Juhl B; Paaske WP; Pedersen EB
    Br J Anaesth; 1997 Dec; 79(6):719-25. PubMed ID: 9496202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition does not prevent the natriuretic effect of felodipine.
    van Hamersvelt HW; Wetzels JF; Kloke HJ; Koene RA; Huysmans FT
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):471-7. PubMed ID: 7681510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
    Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
    JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramipril and felodipine: a comparison of the efficacy and safety of monotherapy versus combination therapy.
    Poisson P; Bauer B; Schueler E; Rangoonwala B
    Curr Med Res Opin; 1996; 13(8):445-56. PubMed ID: 9010611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes.
    Bojestig M; Karlberg BE; Lindström T; Nystrom FH
    Diabetes Care; 2001 May; 24(5):919-24. PubMed ID: 11347755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.